The Manufacturers Life Insurance Company Has $30.17 Million Holdings in MaxLinear, Inc. (NASDAQ:MXL)

The Manufacturers Life Insurance Company increased its position in shares of MaxLinear, Inc. (NASDAQ:MXL - Free Report) by 3,698.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,525,419 shares of the semiconductor company's stock after buying an additional 1,485,256 shares during the quarter. The Manufacturers Life Insurance Company owned about 1.80% of MaxLinear worth $30,173,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of MXL. Assenagon Asset Management S.A. grew its stake in shares of MaxLinear by 339.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,250,769 shares of the semiconductor company's stock worth $24,740,000 after purchasing an additional 966,468 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of MaxLinear by 44.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 935,739 shares of the semiconductor company's stock valued at $13,550,000 after purchasing an additional 288,607 shares in the last quarter. Barclays PLC raised its stake in shares of MaxLinear by 47.6% during the third quarter. Barclays PLC now owns 335,804 shares of the semiconductor company's stock worth $4,860,000 after buying an additional 108,346 shares during the last quarter. Vaughan Nelson Investment Management L.P. lifted its stake in MaxLinear by 10.0% in the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 1,268,857 shares of the semiconductor company's stock valued at $25,098,000 after buying an additional 115,867 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of MaxLinear by 19.1% during the 4th quarter. GAMMA Investing LLC now owns 4,134 shares of the semiconductor company's stock worth $82,000 after purchasing an additional 662 shares in the last quarter. 90.79% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Ted L. Tewksbury III sold 6,071 shares of the company's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $10.40, for a total transaction of $63,138.40. Following the completion of the sale, the director now owns 74,995 shares in the company, valued at $779,948. This represents a 7.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 7.80% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research firms have recently issued reports on MXL. Roth Capital set a $11.00 price target on shares of MaxLinear and gave the company a "neutral" rating in a research note on Thursday, April 24th. Benchmark reaffirmed a "buy" rating and issued a $20.00 price objective on shares of MaxLinear in a research note on Thursday, April 24th. Northland Securities upped their target price on MaxLinear from $25.00 to $27.50 and gave the stock an "outperform" rating in a report on Monday, January 6th. Susquehanna cut their price target on MaxLinear from $25.00 to $23.00 and set a "neutral" rating for the company in a research note on Thursday, January 30th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of MaxLinear in a research report on Thursday, January 30th. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $19.06.

MaxLinear Stock Performance

MaxLinear stock traded up $0.06 during midday trading on Tuesday, hitting $10.69. The company's stock had a trading volume of 506,018 shares, compared to its average volume of 1,414,794. MaxLinear, Inc. has a 1-year low of $8.35 and a 1-year high of $26.59. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.28. The company has a market cap of $904.82 million, a price-to-earnings ratio of -3.63 and a beta of 1.66. The company has a 50-day moving average price of $11.41 and a two-hundred day moving average price of $15.60.

MaxLinear (NASDAQ:MXL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The semiconductor company reported ($0.05) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.05). MaxLinear had a negative return on equity of 21.94% and a negative net margin of 68.01%. The firm had revenue of $95.93 million during the quarter, compared to analyst estimates of $95.32 million. During the same quarter in the previous year, the company posted ($0.21) earnings per share. The company's revenue was up .7% compared to the same quarter last year. As a group, sell-side analysts predict that MaxLinear, Inc. will post -0.37 earnings per share for the current year.

MaxLinear Company Profile

MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.